AWGS2019 vs EWGSOP2 for diagnosing sarcopenia to predict long-term prognosis in Chinese patients with gastric cancer after radical gastrectomy

doi:10.12998/wjcc.v9.i18.4668

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 18

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4169)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

243

WORD

112

HTML

2345

Figures (1-3)

257

Tables (1-2)

139

Sum=3096

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

379

Download

694

Sum=1073

Jun 26, 2021 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Clin Cases. Jun 26, 2021; 9(18): 4668-4680
Published online Jun 26, 2021. doi: 10.12998/wjcc.v9.i18.4668

Table 1 Comparisons between patients with EWGSOP2 and AWGS2019

Factor	AWGS2019 (n = 133)	EWGSOP2 (n = 73)	P value
Age	71.4 ± 8.8	73.3 ± 8.2	0.121
Gender, n (%)			0.018^a
Female	42 (31.6)	12 (16.4)
Male	91 (68.4)	61 (83.6)
BMI	20.4 ± 2.6	20.0 ± 2.5	0.303
Albumin	35.9 ± 4.6	34.8 ± 4.3	0.098
Hypertension, n (%)			0.539
No	93 (69.9)	54 (74.0)
Yes	40 (30.1)	19 (26.0)
Diabetes, n (%)			0.908
No	114 (85.7)	63 (86.3)
Yes	19 (14.3)	10 (13.7)
ASA grade, n (%)			0.239
I	8 (6.0)	4 (5.5)
II	94 (70.7)	44 (60.3)
III	31 (23.3)	25 (34.2)
CCI	5 (5-6)	5 (5-6)	0.109
Operative duration	205.5 ± 55.9	195.0 ± 42.9	0.166
TNM stage, n (%)			0.806
I	23 (17.3)	11 (15.1)
II	28 (21.1)	18 (24.7)
III	82 (61.7)	44 (60.3)
Laparoscopic surgery, n (%)			0.494
No	116 (87.2)	66 (90.4)
Yes	17 (12.8)	7 (9.6)
Type of resection, n (%)			0.922
Subtotal	72 (54.1)	39 (53.4)
Total	61 (45.9)	34 (46.6)
Anastomosis method, n (%)			0.881
B1	41 (30.8)	25 (34.2)
B2	27 (20.3)	14 (19.2)
RY	65 (48.9)	34 (46.6)
Lymph node dissection, n (%)			0.073
D1	18 (13.5)	4 (5.5)
D2	115 (86.5)	69 (94.5)
Differentiation, n (%)			0.438
Differentiated	30 (22.6)	20 (27.4)
Undifferentiated	103 (77.4)	53 (72.6)
Total complications, n (%)	40 (30.1)	25 (34.2)	0.538
Pneumonia	17 (12.8)	10 (13.7)	0.852
Leakage	5 (3.8)	3 (4.1)	0.901
Wound infection	4 (3.0)	2 (2.7)	0.913
Intestinal obstruction	3 (2.3)	1 (1.4)	0.659
Gastrointestinal dysfunction	6 (4.5)	4 (5.5)	0.757
Intra-abdominal infection	7 (5.3)	5 (6.8)	0.642
Intra-abdominal hemorrhage	4 (3.0)	3 (4.1)	0.676
Venous thrombosis	2 (1.5)	1 (1.4)	0.939
First time to flatus	4 (3-5)	4 (3-6)	0.594
Hospital stay	16 (12-21)	16 (12-22)	0.566
Readmission within 30 d	8 (6.0%)	3 (4.1%)	0.561

^aP < 0.05. BMI: Body mass index; CCI: Charlson comorbidity index; ASA: American Society of Anesthesiologists.

Table 2 Univariate and multivariate analyses for predictors of disease-free survival

Factor	Univariable analysis		Multivariate analysis
			AWGS2019		EWGSOP2
	HR (95%CI)	P value	HR (95%CI)	P value	HR (95%CI)	P value
AWGS2019	3.311 (2.470-4.439)	0.001^b	2.150 (1.547-2.988)	0.001^b
EWGSOP2	2.566 (1.803-3.651)	0.001^b			1.599 (1.092-2.339)	0.016^a
Age	1.036 (1.021-1.051)	0.001^b
Gender
Male/female	1.038 (0.745-1.448)	0.824
BMI	0.934 (0.890-0.980)	0.005^b
Albumin	0.930 (0.904-0.957)	0.001^b
Hypertension
Yes/No	1.290 (0.948-1.755)	0.105
Diabetes
Yes/No	0.765 (0.476-1.229)	0.268
ASA grade
II/I	1.301 (0.773-2.190)	0.323
III/I	2.402 (1.366-4.225)	0.002^b
CCI	1.288 (1.146-1.448)	0.001^b
Operative duration	1.003 (1.001-1.006)	0.017^a
TNM stage
II/I	2.494 (1.349-4.610)	0.004^b	1.660 (0.887-3.108)	0.113	1.636 (0.872-3.067)	0.125
III/I	8.093 (4.825-13.574)	0.001^b	4.751 (2.753-8.200)	0.001^b	4.968 (2.876-8.582)	0.001^b
Laparoscopic surgery
Yes/No	0.463 (0.306-0.700)	0.001^b
Type of resection
Total/Subtotal	1.864 (1.400-2.481)	0.001^b
Anastomosis method
B2/B1	2.571 (1.672-3.954)	0.001^b	1.414 (0.904-2.210)	0.129	1.423 (0.911-2.223)	0.122
RouY/B1	2.747 (1.920-3.390)	0.001^b	1.614 (1.109-2.348)	0.012^a	1.600 (1.100-2.328)	0.014^a
Lymph node dissection
D2/D1	1.036 (0.693-1.548)	0.864
Histologic type
Undifferentiated/differentiated	2.756 (1.855-4.095)	0.001^b	1.899 (1.263-2.856)	0.002^b	1.972 (1.309-2.970)	0.001^b
Total complications	1.678 (1.221-2.307)	0.001^b
Pneumonia	2.574 (1.601-4.137)	0.001^b	1.990 (1.222-3.241)	0.006^b	1.935 (1.184-3.163)	0.008^b
Leakage	3.325 (1.757-6.292)	0.001^b	3.018 (1.557-5.853)	0.001^b	3.339 (1.722-6.476)	0.001^b
Wound infection	1.171 (0.435-3.153)	0.755
Intestinal obstruction	2.159 (0.888-5.252)	0.090
Gastrointestinal dysfunction	0.982 (0.484-1.994)	0.960
Intra-abdominal infection	1.410 (0.767-2.594)	0.269
Intra-abdominal hemorrhage	0.888 (0.365-2.160)	0.794
Venous thrombosis	0.997 (0.410-2.425)	0.995
First time to Flatus	1.101 (1.050-1.154)	0.001^b
Hospital stay	1.026 (1.017-1.035)	0.001^b
Readmission within 30 d	1.601 (0.929-2.759)	0.090

^aP < 0.05.

^bP < 0.01. BMI: Body mass index; CCI: Charlson comorbidity index; ASA: American Society of Anesthesiologists; HR: Hazard ratio; CI: Confidence interval.

Citation: Wu WY, Dong JJ, Huang XC, Chen ZJ, Chen XL, Dong QT, Bai YY. AWGS2019 vs EWGSOP2 for diagnosing sarcopenia to predict long-term prognosis in Chinese patients with gastric cancer after radical gastrectomy . World J Clin Cases 2021; 9(18): 4668-4680
URL: https://www.wjgnet.com/2307-8960/full/v9/i18/4668.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i18.4668